SAGA Diagnostics
Business Services · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
860 Aviation Pkwy Ste 300, Morrisville, ...Phone Number
(919) 371-0283Website
www.sagadiagnostics.comRevenue
$49.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About SAGA Diagnostics
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive "liquid biopsies" such as blood samples.Explore more
SAGA Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SAGA Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
SAGA Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if SAGA Diagnostics had a recent Job posting/layoffs
Product Launch: Get notified when SAGA Diagnostics launches new products
Funding: Get notified immidiatlly once SAGA Diagnostics has new funding data
Check if SAGA Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Check out if SAGA Diagnostics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SAGA Diagnostics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at SAGA Diagnostics
Recommended Actions
Reach out to Masked Content who joined SAGA Diagnostics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
SAGA Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SAGA Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SAGA Diagnostics.
SAGA Diagnostics financials insights
Gather financial insights about SAGA Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$12.5M
SAGA Diagnostics Tech Stack
A closer look at the technologies used by SAGA Diagnostics
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
SAGA Diagnostics News & Media
SAGA Diagnostics appoints Peter Collins as Chief Executive Officer
LUND, Sweden - /October 7, 2021/ – SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, is pleased to announce the appointment of Peter Collins as Chief Executive Officer. Mr. Collins is a highly experienced entrepreneur with over 30 years of experience in the pharma and diagnostics sector. He joins SAGA after successful executive roles at major players in the liquid biopsy field such as Inivata as Chief Business Officer andSegulah Medical Acceleration Announces Investment in SAGA Diagnostics
Segulah Medical Acceleration AB (SMA) announced today that it has invested in cancer liquid biopsy and genomic testing company SAGA Diagnostics’ oversubscribed SEK 106 million (€10.5 million) Series A2 equity financing round. The round was led by SMA together with the Sciety investment syndicate with strong support from existing shareholders such as Hadean Ventures. SAGA is commercializing proprietary technologies to quantify cancer-associated genetic aberrations in tissue and liquid biopsy sampSAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies
LUND, Sweden and STOCKHOLM, June 29, 2021 /PRNewswire/ -- SAGA Diagnostics AB ("SAGA"), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. The Series A2 round...SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ...
/PRNewswire/ -- SAGA Diagnostics AB ("SAGA"), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SAGA Diagnostics
Sign Up For FreeTo access detailed company insights
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company that offers molecular genetic testing of tissue biopsies and non-invasive "liquid biopsies" such as blood samples.... Read More
